Roderick de Greef - 19 Oct 2023 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: President and CEO, Director
Signature: /s/ Roderick de Greef
Issuer symbol: BLFS
Transactions as of: 19 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 01 Nov 2023, 17:29:53 UTC
Previous filing: 10 Oct 2023
Next filing: 23 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLFS	Common Stock	Award		+394,856	+828%		442,539	19 Oct 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BLFS	Restricted Stock Award	Award	$0	+394,856		$0.000000	394,856	19 Oct 2023	Common Stock	394,856	$0.000000	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of their employment agreement.
F2	This reflects the total amount beneficially owned by the reporting person as of October 19, 2023. Previous Form 4's filed by the reporting person before October 19, 2023 did not reflect the acquisition of 2,421 shares.
F3	The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027.